Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo
Open accessThe DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
Lentivirus-derived vectors are among the most promising viral vectors for gene therapy currently available, but their use in clinical practice is limited by the associated risk of insertional mutagenesis. We have overcome this problem by developing a nonintegrative lentiviral vector derived from HIV type 1 with a class 1 integrase (IN) mutation (replacement of the 262 RRK motif by AAH). We generated and characterized HIV type 1 vectors carrying this deficient enzyme and expressing the GFP or neomycin phosphotransferase transgene ( NEO ) under control of the immediate early promoter of human CMV. These mutant vectors efficiently transduced dividing cell lines and nondividing neural primary cultures in vitro . After transduction, transient GFP fluorescence was observed in dividing cells, whereas long-term GFP fluorescence was observed in nondividing cells, consistent with the viral genome remaining episomal. Moreover, G418 selection of cells transduced with vectors expressing the NEO gene showed that residual integration activity was lower than that of the intact IN by a factor of 500–1,250. These nonintegrative vectors were also efficient in vivo , allowing GFP expression in mouse brain cells after the stereotactic injection of IN-deficient vector particles. Thus, we have developed a generation of lentiviral vectors with a nonintegrative phenotype of great potential value for secure viral gene transfer in clinical applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“NILVs encoding for in vivo expression of GFP have been reported in organs such as the brain, liver, and spinal cord via stable gene transfer for longer periods (up to months) in several studies [22,73,131,132,133,134].”
From Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through (2022) · cites this paper as [133]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“NILVs, which are deficient in the viral integrase protein, can transduce both dividing and non-dividing cells, and the viral genome remains present in the cell as an episome rather than integrating into the host genomic DNA [87].”
From Clinical use of lentiviral vectors (2018) · cites this paper as [87]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A non-integrating LV was engineered to avoid unwanted integration. In these vectors, selected mutations were induced within the integrase coding region to eliminate the integrase activities without affecting reverse transcription and transport of the pre-integrating complex into the nucleus [48,49,50].”
From Viral Delivery Systems for CRISPR (2019) · cites this paper as [48]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., & Trono, D. (1997) · Nature Biotechnology · doi:10.1038/nbt0997-871 · Cited by 1,977
A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency
Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., Le Deist, F., Wulffraat, N., McIntyre, E., Radford, I., Villeval, J.-L., Fraser, C. C., Cavazzana-Calvo, M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejm200301163480314 · Cited by 1,867
HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
Schröder, A. R. W., Shinn, P., Chen, H., Berry, C., Ecker, J. R., & Bushman, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00864-4 · Cited by 1,832
Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery
Zufferey, R., Dull, T., Mandel, R. J., Bukovsky, A., Quiroz, D., Naldini, L., & Trono, D. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9873-9880.1998 · Cited by 1,815
Naldini, L., Blömer, U., Gage, F. H., Trono, D., & Verma, I. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11382 · Cited by 1,499
Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration
Wu, X., Li, Y., Crise, B., & Burgess, S. M. (2003) · Science · doi:10.1126/science.1083413 · Cited by 1,305
Development of a self-inactivating lentivirus vector
Miyoshi, H., Blömer, U., Takahashi, M., Gage, F. H., & Verma, I. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.8150-8157.1998 · Cited by 1,196
Zufferey, R., Donello, J. E., Trono, D., & Hope, T. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.2886-2892.1999 · Cited by 1,014
Follenzi, A., Ailles, L. E., Bakovic, S., Geuna, M., & Naldini, L. (2000) · Nature Genetics · doi:10.1038/76095 · Cited by 927
HIV-1 Genome Nuclear Import Is Mediated by a Central DNA Flap
Zennou, V., Petit, C., Guetard, D., Nerhbass, U., Montagnier, L., & Charneau, P. (2000) · Cell · doi:10.1016/s0092-8674(00)80828-4 · Cited by 833
Self-citationSustained expression of genes delivered directly into liver and muscle by lentiviral vectors
Kafri, T., Blömer, U., Peterson, D. A., Gage, F. H., & Verma, I. M. (1997) · Nature Genetics · doi:10.1038/ng1197-314 · Cited by 605
Effective gene therapy with nonintegrating lentiviral vectors
Yáñez-Muñoz, R. J., Balaggan, K. S., MacNeil, A., Howe, S. J., Schmidt, M., Smith, A. J., Buch, P., MacLaren, R. E., Anderson, P. N., Barker, S. E., et al. (2006) · Nature Medicine · doi:10.1038/nm1365 · Cited by 460
Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication
Engelman, A., Englund, G., Orenstein, J. M., Martin, M. A., & Craigie, R. (1995) · Journal of Virology · doi:10.1128/jvi.69.5.2729-2736.1995 · Cited by 445
Wiskerchen, M., & Muesing, M. A. (1995) · Journal of Virology · doi:10.1128/jvi.69.1.376-386.1995 · Cited by 273
Themis, M., Waddington, S. N., Schmidt, M., von Kalle, C., Wang, Y., Al-Allaf, F., Gregory, L. G., Nivsarkar, M., Themis, M., Holder, M. V., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.07.358 · Cited by 243
Polyclonal long-term repopulating stem cell clones in a primate model
Schmidt, M. (2002) · Blood · doi:10.1182/blood-2002-02-0407 · Cited by 218
The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain
Zennou, V., Serguera, C., Sarkis, C., Colin, P., Perret, E., Mallet, J., & Charneau, P. (2001) · Nature Biotechnology · doi:10.1038/88115 · Cited by 214
Self-citationIntegration is not necessary for expression of human immunodeficiency virus type 1 protein products
Stevenson, M., Haggerty, S., Lamonica, C. A., Meier, C. M., Welch, S. K., & Wasiak, A. J. (1990) · Journal of Virology · doi:10.1128/jvi.64.5.2421-2425.1990 · Cited by 206
Abordo-Adesida, E., Follenzi, A., Barcia, C., Sciascia, S., Castro, M. G., Naldini, L., & Lowenstein, P. R. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.741 · Cited by 170
Cancer Incidence in New York State Acquired Immunodeficiency Syndrome Patients
Gallagher, B. K. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.6.544 · Cited by 151
Circularization of human immunodeficiency virus type 1 DNA in vitro
Farnet, C. M., & Haseltine, W. A. (1991) · Journal of Virology · doi:10.1128/jvi.65.12.6942-6952.1991 · Cited by 148
HIV-1 gene expression: lessons from provirus and non-integrated DNA
Wu, Y. (2004) · Retrovirology · doi:10.1186/1742-4690-1-13 · Cited by 124
Saenz, D. T., Loewen, N., Peretz, M., Whitwam, T., Barraza, R., Howell, K. G., Holmes, J. M., Good, M., & Poeschla, E. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.2906-2920.2004 · Cited by 119
Nakajima, N., Lu, R., & Engelman, A. (2001) · Journal of Virology · doi:10.1128/jvi.75.17.7944-7955.2001 · Cited by 113
Papapetrou, E. P., Ziros, P. G., Micheva, I., Zoumbos, N. C., & Athanassiadou, A. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302593 · Cited by 98
Applications of gene therapy to the CNS
Blömer, U., Naldini, L., Verma, I. M., Trono, D., & Gage, F. H. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.supplement_1.1397 · Cited by 88
Petit, C., Schwartz, O., & Mammano, F. (2000) · Journal of Virology · doi:10.1128/jvi.74.15.7119-7126.2000 · Cited by 78
Self-citationOptimization of the Generation and Propagation of Gutless Adenoviral Vectors
Sakhuja, K., Reddy, P. S., Ganesh, S., Cantaniag, F., Pattison, S., Limbach, P., Kayda, D. B., Kadan, M. J., Kaleko, M., & Connelly, S. (2003) · Human Gene Therapy · doi:10.1089/10430340360535797 · Cited by 75
A Single Lentivirus Vector Mediates Doxycycline-Regulated Expression of Transgenes in the Brain
Vogel, R., Amar, L., Thi, A. D., Saillour, P., & Mallet, J. (2004) · Human Gene Therapy · doi:10.1089/104303404772679968 · Cited by 68
Self-citationCannon, P. M., Byles, E. D., Kingsman, S. M., & Kingsman, A. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.651-657.1996 · Cited by 63
Brun, S., Biguet, N. F., & Mallet, J. J. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00097-2 · Cited by 61
Self-citationIdentification of a Central DNA Flap in Feline Immunodeficiency Virus
Whitwam, T., Peretz, M., & Poeschla, E. (2001) · Journal of Virology · doi:10.1128/jvi.75.19.9407-9414.2001 · Cited by 47
Logvinoff, C., & Epstein, A. L. (2001) · Human Gene Therapy · doi:10.1089/104303401750061221 · Cited by 44
Optimization of Cis-Acting Elements for Gene Expression from Nonviral Vectors In Vivo
Ehrhardt, A., Peng, P. D., Xu, H., Meuse, L. A., & Kay, M. A. (2003) · Human Gene Therapy · doi:10.1089/10430340360535779 · Cited by 36
Loewen, N., Leske, D. A., Chen, Y., Teo, W., Saenz, D. T., Peretz, M., Holmes, J. M., & Poeschla, E. M. (2003) · The Journal of Gene Medicine · doi:10.1002/jgm.447 · Cited by 36
Chen, H., & Engelman, A. (2000) · Journal of Virology · doi:10.1128/jvi.74.17.8188-8193.2000 · Cited by 17
Preferential HIV-1 integration sites in macrophages and HIV-associated malignancies.
Da, K., Troelstrup, D., & Shiramizu, B. T. (2004) · PubMed · Cited by 11
Nucleic Acid-Matrix Attachment Recognition Regions--As Facilitators in Plasmid Transfer
Chancham, P., van Ijperen, T., McDoom, I., & Hughes, J. A. (2003) · Journal of drug targeting · doi:10.1080/10611860310001603823 · Cited by 7
Research works printed but not linked: 2
- DA Killebrew, D Troelstrup, B Shiramizu Cell Mol Biol 50, 581–589 (2004).
- JM Coffin Fields Virology, eds NB Fields, DM Knipe, PM Howley, RM Chanock, JL Melnick, TP Monath, B Roizman, SE Straus (Lippincott-Raven, Philadelphia), pp. 1767–1847 (1996).
Cited by
Clinical use of lentiviral vectors
Milone, M. C., & O’Doherty, U. (2018) · Leukemia · doi:10.1038/s41375-018-0106-0 · Cited by 930
“viral genome remains present in the cell as an episome rather than integrating into the host genomic DNA [87].”
BackgroundLombardo, A., Genovese, P., Beausejour, C. M., Colleoni, S., Lee, Y.-L., Kim, K. A., Ando, D., Urnov, F. D., Galli, C., Gregory, P. D., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1353 · Cited by 845
Gene delivery by lentivirus vectors
Cockrell, A. S., & Kafri, T. (2007) · Molecular Biotechnology · doi:10.1007/s12033-007-0010-8 · Cited by 355
“Most recently, however, two groups employed packaging cassettes harboring distinct mutations to demonstrate efficient in vivo transgene delivery in ocular and brain tissues [76, 77].”
BackgroundRecent Advances in Lentiviral Vector Development and Applications
Mátrai, J., Chuah, M. K., & VandenDriessche, T. (2010) · Molecular Therapy · doi:10.1038/mt.2009.319 · Cited by 347
Lentiviral Vectors in Gene Therapy: Their Current Status and Future Potential
Escors, D., & Breckpot, K. (2010) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-010-0063-4 · Cited by 344
“Then, the lentivector DNA remains in the nucleus as an episome, leading to sustained expression in post-mitotic cells and tissues such as retina, brain, and muscle (Apolonia et al. 2007; Philippe et al. 2006; Yanez-Munoz et al. 2006).”
Metadata
- Authors
- Philippe, S., Sarkis, C., Barkats, M., Mammeri, H., Ladroue, C., Petit, C., Mallet, J., & Serguera, C.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- *Laboratoire de Génétique Moléculaire de la Neurotransmission et des Processus Neurodégénératifs, Université Pierre et Marie Curie Paris 6, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7091, 83 bd de l'Hôpital, 75013 Paris, France; and
- ORCID
- Philippe, Stéphanie
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-11-21
- Volume
- 103
- Issue
- 47
- Pages
- 17684-17689
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1693807
- OpenAlex
- W2027296526
- Semantic Scholar
- b3b8cee98153531af5a2ea2aa720083aad289a9f
- Cited by
- 249
- References
- 40
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 10 · 2023: 6 · 2022: 11 · 2021: 6 · 2020: 7 · 2019: 8 · 2018: 10 · 2017: 14 · 2016: 11 · 2015: 16 · 2014: 17 · 2013: 11 · 2012: 21
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Keywords
- lentiviral vectors, HIV-1, insertional mutagenesis, transgene expression, neural cells, stereotactic injection, gene therapy, neomycin phosphotransferase
- MeSH terms
- Animals, Brain, Cells, Cultured, Genetic Vectors, Humans, Plasmids, Recombinant Fusion Proteins, Genetic Therapy, HIV-1, Lentivirus, Genome, Viral, Rats, Sprague-Dawley, Gene Transfer Techniques, Transgenes, Integrases, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.